Literature DB >> 1251350

The observation of heparin on endothelium after injection.

L M Hiebert, L B Jaques.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1251350     DOI： 10.1016/0049-3848(76)90262-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  21 in total

1.  In vitro and in vivo correlation of clotting protease activity: effect of heparin.

Authors:  S N Gitel; R C Stephenson; S Wessler
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality.

Authors:  J J Sayen; R B Singer; G Peirce; O Horwitz
Journal:  Trans Am Clin Climatol Assoc       Date:  1983

Review 3.  Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors:  Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-07-09       Impact factor: 4.335

4.  The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells.

Authors:  A Smailbegovic; R Lever; C P Page
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Heparin protects human endothelial cells infected by Rickettsia rickettsii.

Authors:  D J Silverman; L A Santucci; Z Sekeyova
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  The effects of heparin treatment on vascular permeability and vessel wall damage in acute hypertension in the rat.

Authors:  S K Wilson; R H Heptinstall
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

7.  Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.

Authors:  Edward N Harris; Bruce A Baggenstoss; Paul H Weigel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

8.  Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth.

Authors:  Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.200

Review 9.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

10.  Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors.

Authors:  M Klagsbrun; Y Shing
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.